January 2021
MSD
Results Healthcare has advised MSD on the divestment of its Mirabel manufacturing site in Riom France, to Fareva
Results Healthcare is delighted to have acted as the exclusive advisor to MSD, a leading global biopharmaceutical company, on the divestment of its Mirabel manufacturing site located in Riom France, to Fareva, one of the world’s leading CDMOs in the pharmaceuticals sector.
The transaction includes the transfer of approximately 350 employees to Fareva and substantial future investment into the site. Fareva expects this investment will enable long-term growth and potential job creation at the site.
This cross-border transaction highlights Results Healthcare’s excellent reputation in the healthcare and life sciences sector and is a testament to its international network.
More Like This
-
C$3.3bdentalcorp
Financial Advisor to dentalcorp Holdings on its Sale to GTCR
-
Kent-Athlone Pharma Group
Exclusive Financial Advisor to Kent-Athlone Pharma Group on the Sale of Athlone Laboratories to Gaelic Laboratories
-
US$140mTrulieve Cannabis
Sole Agent and Sole Bookrunner (Senior Secured Notes Offering)